82_FR_51652 82 FR 51439 - Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation

82 FR 51439 - Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 82, Issue 213 (November 6, 2017)

Page Range51439-51440
FR Document2017-24090

Federal Register, Volume 82 Issue 213 (Monday, November 6, 2017) 
[Federal Register Volume 82, Number 213 (Monday, November 6, 2017)]
[Notices]
[Pages 51439-51440]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-24090]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: 
Cerilliant Corporation

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before January 5, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on May 
23, 2017, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round 
Rock, Texas 78665-2402 applied to be registered as a bulk manufacturer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-             7010  I
 oxobutan-2-yl)-1-)4-fluorobenzyl)-1-H-
 indazole-3-carboxamide).
MDMB-FUBINACA (Methyl-2-(1-(4-                       7020  I
 fluorobenzyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-              7032  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).

[[Page 51440]]

 
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1-1H-           7033  I
 indazole-3-carboxamido)-3-
 methylbutanoate).
5F-ADB;5F-MDMB-PINACA (Methyl 2-(1-(5-               7034  I
 fluoropentyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-              7042  I
 (cyclohenxylmethyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanoate).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-            7049  I
 1-(5-fluoropentyl)-1-1H-indazole-3-
 carboxamide).
U-47700 (3,4-dichloro-N-[2-                          9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
Acryl fentanyl (N-(1-phenethylpiperidin-4-           9811  I
 yl)-N-phenylacrylamide).
4-Fluoroisobutyryl fentanyl (N-(4-                   9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-4-
 yl)isobutyramide).
Furanyl fentanyl (N-(1-phenethylpiperidin-           9834  I
 4-yl)-N-phenylfuran-2-carboxamide).
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards which will be 
distributed to its customers.

    Dated: October 27, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-24090 Filed 11-3-17; 8:45 am]
 BILLING CODE 4410-09-P

Federal Register / Vol. 82, No. 213 / Monday, November 6, 2017 / Notices 51439 Registrant, both with respect to the he was hospitalized for an overdose on United States. This Order is applicable volume of drugs being diverted and by multiple occasions), establishes that December 6, 2017. denying that he was engaged in there was ‘‘a substantial likelihood of an Dated: October 31, 2017. diverting and abusing the controlled immediate threat that death, serious Robert W. Patterson, substances. As explained above, bodily harm, or abuse of a controlled Acting Administrator. Registrant’s and Chapman’s misconduct substance [would] occur in the absence in diverting drugs, which the latter [FR Doc. 2017–24093 Filed 11–3–17; 8:45 am] of the immediate suspension of personally abused, was actionable [Registrant’] registration.’’ Id. I therefor BILLING CODE 4410–09–P misconduct under both Factor Four affirm the issuance of the Immediate (compliance with applicable laws Suspension Order. related to controlled substances) and DEPARTMENT OF JUSTICE Pursuant to 21 U.S.C. 824(f), ‘‘[u]pon Factor Five (other conduct which may a revocation order becoming final, all Drug Enforcement Administration threaten public health and safety). As . . . controlled substances’’ seized the DI explained, had Chapman been pursuant to a suspension order ‘‘shall be candid during the June 30, 2016 [Docket No. DEA–392] forfeited to the United States’’ and ‘‘[a]ll interview, he and his colleagues ‘‘would right, title, and interest in such Bulk Manufacturer of Controlled have pursued immediate criminal action controlled substances shall vest in the Substances Application: Cerilliant against Chapman’’ as well as United States upon a revocation order Corporation administrative action against Registrant. becoming final.’’ As the Agency has Indeed, Chapman’s subsequent previously held, a registrant cannot ACTION: Notice of application. admissions during the July 22, 2016 defeat the effect of this provision by interview supported both criminal allowing its registration to expire.’’ DATES: Registered bulk manufacturers of charges against Chapman and the S & S Pharmacy, Inc., d/b/a Platinum the affected basic classes, and Immediate Suspension Order. Pharmacy & Compounding, 78 FR Accordingly, I conclude that the applicants therefore, may file written 57656, 57659 (2013) (citing comments on or objections to the evidence with respect to Factor Five Meetinghouse Community Pharmacy, establishes that Registrant’s principal issuance of the proposed registration on Inc., 74 FR 10073, 10074 n.5 (2009); RX or before January 5, 2018. was abusing controlled substances and Direct Pharmacy, Inc., 72 FR 54070, that he made several materially false ADDRESSES: Written comments should 54072 n.4 (2007)). Registrant had the statements to DEA investigators. I also be sent to: Drug Enforcement right to challenge the Immediate conclude that these acts constitute Administration, Attention: DEA Federal Suspension Order before the Agency but actionable misconduct which may Register Representative/DRW, 8701 chose not to. And had Registrant not threaten public health and safety. Morrissette Drive, Springfield, Virginia allowed its registration to expire, I 22152. Summary of Factors Four and Five and would have revoked it. Imminent Danger Accordingly, I will order that the SUPPLEMENTARY INFORMATION: The As found above, the Government’s controlled substances seized pursuant to Attorney General has delegated his evidence establishes that Registrant the Immediate Suspension Order be authority under the Controlled unlawfully distributed controlled forfeited to the United States. 21 U.S.C. Substances Act to the Administrator of substances to Chapman and failed to 824(f). I will also declare that ‘‘[a]ll, the Drug Enforcement Administration maintain required records. The evidence right, title, and interest in’’ the (DEA), 28 CFR 0.100(b). Authority to also establishes that Registrant’s controlled substances that were seized exercise all necessary functions with principal and pharmacist in charge pursuant to the Suspension Order have respect to the promulgation and unlawfully possessed controlled vested in the United States. Id. implementation of 21 CFR part 1301, substances, destroyed records that incident to the registration of Order manufacturers, distributors, dispensers, Registrant was required to maintain, abused controlled substances and made Pursuant to the authority vested in me importers, and exporters of controlled materially false statements to DEA by 21 U.S.C. 824(a) and (d), as well as substances (other than final orders in Investigators. I therefore find that 28 CFR 0.100(b), I order that the Order connection with suspension, denial, or Registrant has committed such acts as to of Immediate Suspension issued to Chip revocation of registration) has been render its registration inconsistent with RX d/b/a City Center Pharmacy be, and redelegated to the Assistant the public interest. 21 U.S.C. 824(a)(4). it hereby is, affirmed. Pursuant to the Administrator of the DEA Diversion For purposes of the imminent danger authority vested in me by 21 U.S.C. Control Division (‘‘Assistant inquiry, these findings also support the 824(f), I order that all controlled Administrator’’) pursuant to section 7 of conclusion that Registrant has ‘‘fail[ed] substances seized pursuant to the Order 28 CFR part 0, appendix to subpart R. . . . to maintain effective controls of Immediate Suspension be, and they In accordance with 21 CFR against diversion or otherwise comply hereby are, forfeited to the United 1301.33(a), this is notice that on May 23, with the obligations of a registrant States. Pursuant to the authority vested 2017, Cerilliant Corporation, 811 under’’ the CSA. 21 U.S.C. 824(d)(2). in me by 21 U.S.C. 824(f), I also declare Paloma Drive, Suite A, Round Rock, Also, the evidence that Chapman was that all right, title, and interest in all Texas 78665–2402 applied to be diverting 200 to 300 milligrams of controlled substances seized pursuant to registered as a bulk manufacturer of the Pmangrum on DSK3GDR082PROD with NOTICES narcotics per day, which he then abused the Order of Immediate Suspension be, following basic classes of controlled (along with the evidence showing that and they hereby are, vested in the substances: Controlled substance Drug code Schedule ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-)4-fluorobenzyl)-1-H-indazole-3-carboxamide) ............ 7010 I MDMB-FUBINACA (Methyl-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ....................... 7020 I MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ......... 7032 I VerDate Sep<11>2014 14:48 Nov 03, 2017 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\06NON1.SGM 06NON1

51440 Federal Register / Vol. 82, No. 213 / Monday, November 6, 2017 / Notices Controlled substance Drug code Schedule 5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1-1H-indazole-3-carboxamido)-3-methylbutanoate) ............................................ 7033 I 5F-ADB;5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......... 7034 I MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohenxylmethyl)-1H-indole-3-carboxamido)-3,3- 7042 I dimethylbutanoate). 5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1-1H-indazole-3-carboxamide) ................................. 7049 I U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ............................................................... 9547 I Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. 9811 I 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... 9824 I Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. 9834 I The company plans to manufacture Other important dates: The current competition, Phase 3 (On- small quantities of the listed controlled May 16, 2018 Level 1: Virtual Site Habitat), will focus on the substances to make reference standards Construction Building Information technology for autonomous 3D-printing which will be distributed to its Modeling (BIM)—60% Design Results and construction of a complete 1:3 sub- customers. due to Judges scale habitat (∼10 m2). This competition Dated: October 27, 2017. July 11, 2018 Level 2: Foundation Test will involve elements from Phase 1 Demetra Ashley, Results due to Judges design and Phase 2 materials to December 5, 2018 Level 3: Hydrostatic demonstrate the technology for Acting Assistant Administrator. Test Results due to Judges autonomous construction needed for [FR Doc. 2017–24090 Filed 11–3–17; 8:45 am] January 16, 2019 Level 4: Virtual building a habitat on another planet or BILLING CODE 4410–09–P even on remote locations on Earth. Construction BIM—100% Design Results due to Judges A Phase 4 competition (Full-Scale April 29—May 4, 2019 Level 5: Subscale Habitat), calling for the development of NATIONAL AERONAUTICS AND Habitat Competition an autonomous 3D-printed construction SPACE ADMINISTRATION of a full-scale habitat (∼93 m2), is ADDRESSES: The Level 5 On-Site [Notice: (16–083)] Subscale Habitat Head-to-Head planned to be announced at a later date. challenge competition will take place at: I. Prize Amounts Centennial Challenges: 3D-Printed Caterpillar Edwards Demonstration and Habitat Challenge Learning Center, 5801 N. Smith Rd., The 3D Printed Habitat Challenge Edwards, IL 61528. Phase 3 On-Site Habitat Competition AGENCY: National Aeronautics and purse is $2,000,000 (two million dollars) Space Administration (NASA). FOR FURTHER INFORMATION CONTACT: To to be disbursed as follows: ACTION: Notice of Centennial Challenges register for or get additional information 3D-Printed Habitat Challenge Phase 3: regarding the 3D Printed Habitat Level 1: Virtual Construction BIM—60% On-Site Habitat Competition. Challenge, please visit: http:// Design bradley.edu/challenge For general $100,000 total prize money to be SUMMARY: The 3D-Printed Habitat information on the NASA Centennial awarded to top 5 qualifiers based on (3DPH) Challenge Phase 3 On-Site Challenges Program please visit: http:// scoring, as articulated in the Habitat Competition is open, and teams www.nasa.gov/challenges. General competition rules. that wish to compete may now register. questions and comments regarding the Centennial Challenges is a program of program should be addressed to Monsi Level 2: Foundation Test prize competitions to stimulate Roman, Centennial Challenges Program, $400,000 total prize money to be innovation in technologies of interest NASA Marshall Space Flight Center awarded to top 10 qualifiers based on and value to NASA and the nation. The Huntsville, AL 35812. Email address: scoring, as articulated in the 3DPH Challenge Phase 3 On-Site Habitat hq-stmd-centennialchallenges@ competition rules. Competition is a prize competition with mail.nasa.gov. a $2,000,000 total prize purse to develop Level 3: Hydrostatic Test SUPPLEMENTARY INFORMATION: and demonstrate capabilities to $600,000 total prize money to be autonomously manufacture through 3D- Summary awarded to top 8 qualifiers based on printing technologies a habitat on The 3DPH Challenge Phase 3 scoring, as articulated in the another planetary body using mission Competition (On-Site Habitat) follows competition rules. recycled materials and/or local earlier phases of the Challenge as indigenous materials. The Phase 3 Level 4: Virtual Construction BIM— described below. competition consists of 5 levels. This 100% Design • Design Competition (Phase 1)— technology demonstration competition focused on developing innovative $100,000 total prize money to be has great potential value for terrestrial habitat architectural concepts that take awarded to top 3 qualifiers based on applications. advantage of the unique capabilities that scoring, as articulated in the DATES: Challenge registration opens 3D-Printing offers (completed in 2015). competition rules. • Structural Member Competition Pmangrum on DSK3GDR082PROD with NOTICES November 7, 2017, and will remain Level 5: Subscale Habitat Competition open until February 15, 2018. Early and (Phase 2)—focused on the core 3D- Late registrations are available with Printing fabrication technologies and $500,000 to first place discount or late fee respectively. materials properties needed to $200,000 to second place Competitors will be allowed the option manufacture structural components $100,000 to third place to participate in the Virtual from indigenous materials combined These awards will be made based on Construction competitions levels 1 & 4 with recyclables, or indigenous scoring, as articulated in the only with a reduced registration fee. materials alone (completed in 2017). competition rules. VerDate Sep<11>2014 14:48 Nov 03, 2017 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\06NON1.SGM 06NON1


Document Created: 2017-11-07 10:30:50
Document Modified: 2017-11-07 10:30:50
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of application.
DatesRegistered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 5, 2018.
FR Citation82 FR 51439 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR